Clinical Outcomes in Patients with Parkinson's Disease Treated with a Monoamine Oxidase Type‐B inhibitor: A Cross‐Sectional, Cohort Study

STUDY OBJECTIVE: To evaluate the long‐term risk of developing cognitive symptoms (e.g., dementia, hallucinations), dyskinesia, falls, and freezing of gait (FoG) in patients with Parkinson's disease (PD) who received monoamine oxidase type B inhibitors (MAOB‐Is) compared with patients who had ne...

Descripción completa

Detalles Bibliográficos
Autores principales: Dashtipour, Khashayar, Chen, Jack J., Kani, Camellia, Bahjri, Khaled, Ghamsary, Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2015
Materias:
Original Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5034746/
https://www.ncbi.nlm.nih.gov/pubmed/26139574
http://dx.doi.org/10.1002/phar.1611

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5034746/
https://www.ncbi.nlm.nih.gov/pubmed/26139574
http://dx.doi.org/10.1002/phar.1611

Ejemplares similares